{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/benzodiazepine-z-drug-withdrawal/how-this-topic-was-developed/declarations-of-interest/","result":{"pageContext":{"chapter":{"id":"7a323840-12e0-545e-87de-461171f81997","slug":"declarations-of-interest","fullItemName":"Declarations of interest","depth":2,"htmlHeader":"<!-- begin field d6589ee5-d2a7-4c2d-acda-a7f30015c30d --><h2>Declarations of interest</h2><!-- end field d6589ee5-d2a7-4c2d-acda-a7f30015c30d -->","summary":null,"htmlStringContent":"<!-- begin item 95470d3d-518a-4738-b595-a7f30015bd73 --><!-- begin field 94e13c27-23cd-400a-a082-a7f30015c30d --><h2>Our policy</h2><!-- end field 94e13c27-23cd-400a-a082-a7f30015c30d --><!-- begin field 473451bd-0951-403c-b81b-a7f30015c30d --><p>Clarity Informatics requests that all those involved in the writing and reviewing of topics, and those involved in the external review process to declare any competing interests. Signed copies are securely held by Clarity Informatics and are available on request with the permission of the individual. A copy of the declaration of interest form which participants are asked to complete annually is also available on request. A brief outline of the declarations of interest policy is described here and full details of the policy is available on the <a href=\"https://cks.clarity.co.uk/\" data-hyperlink-id=\"350f01de-a403-4e5e-bccc-a992002b2a3a\">Clarity Informatics website</a>. Declarations of interests of the authors are not routinely published, however competing interests of all those involved in the topic update or development are listed below. Competing interests include:</p><ul><li>Personal financial interests</li><li>Personal family interest</li><li>Personal non-financial interest</li><li>Non-personal financial gain or benefit</li></ul><p>Although particular attention is given to interests that could result in financial gains or losses for the individual, competing interests may also arise from academic competition or for political, personal, religious, and reputational reasons. An individual is not obliged to seek out knowledge of work done for, or on behalf of, the healthcare industry within the departments for which they are responsible if they would not normally expect to be informed.</p><!-- end field 473451bd-0951-403c-b81b-a7f30015c30d --><!-- begin field 7962e82f-e287-4e5b-b162-a7f30015c30d --><h2>Who should declare competing interests?</h2><!-- end field 7962e82f-e287-4e5b-b162-a7f30015c30d --><!-- begin field 32923393-494f-49b5-a437-a7f30015c30d --><p>Any individual (or organization) involved in developing, reviewing, or commenting on clinical content, particularly the recommendations should declare competing interests. This includes the authoring team members, expert advisers, external reviewers of draft topics, individuals providing feedback on published topics, and Editorial Steering Group members. Declarations of interest are completed annually for authoring team and editorial steering group members, and are completed at the start of the topic update and development process for external stakeholders.</p><!-- end field 32923393-494f-49b5-a437-a7f30015c30d --><!-- begin field 1fed6523-ae93-4df2-bf4b-a7f30015c30d --><h2>Competing interests declared for this topic:</h2><!-- end field 1fed6523-ae93-4df2-bf4b-a7f30015c30d --><!-- begin field a1672157-904d-4dd1-b0d6-a7f30015c30d --><p>None.</p><!-- end field a1672157-904d-4dd1-b0d6-a7f30015c30d --><!-- end item 95470d3d-518a-4738-b595-a7f30015bd73 -->","topic":{"id":"e3f1abb8-a968-53c3-bc6a-12e1b2886ed2","topicId":"35151ccb-5966-4e29-97a4-191f3f2aef6a","topicName":"Benzodiazepine and z-drug withdrawal","slug":"benzodiazepine-z-drug-withdrawal","lastRevised":"Last revised in January 2019","chapters":[{"id":"ddeb227b-ec5e-5a69-b033-23d16e492302","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"ca1d0037-207c-5656-8c1a-64eb8f8a6adf","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"4f9475f8-9d93-5b3d-9cc7-66f08d975494","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"33c4d415-a5bf-586c-af94-95833f29167f","slug":"changes","fullItemName":"Changes"},{"id":"814181c9-c71c-54f0-a9f2-a7b2a5f73459","slug":"update","fullItemName":"Update"}]},{"id":"2237f5ce-b47f-5f59-80d4-2098a2fafae1","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"14f4d723-2346-5509-b69f-ec1690c54f89","slug":"goals","fullItemName":"Goals"},{"id":"978d3882-5b77-58d0-9081-5f1879a2e244","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"df6950b2-9910-5c3e-9f7e-a89c359ba5cf","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"f78c4bb6-5d1b-516c-acb6-5a8a6add79ec","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"1d88ca0e-4d2b-56ae-9602-a213d4c8767e","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"00453e06-07ba-5d13-a4f0-dfd3b6e7dfa4","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"058ea4e2-b85f-5dbf-885b-f3a39f06d48c","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"24a95463-c4af-5572-b06f-acf2f15c47d1","slug":"definition","fullItemName":"Definition"},{"id":"fbb9e10e-ed3c-51d5-b3fa-e2d482b83413","slug":"prevalance","fullItemName":"Prevalance"},{"id":"32dfcd69-3d5d-5897-bd8f-cee84b53b670","slug":"risk-factors","fullItemName":"Risk factors"},{"id":"d110deb7-70d0-5c76-8606-a9af49e97f91","slug":"complications","fullItemName":"Complications"},{"id":"c26626ad-6167-542c-98fe-a2ff03221e61","slug":"prognosis","fullItemName":"Prognosis"}]},{"id":"a846d324-cab9-57dd-a619-3bf18b540356","fullItemName":"Management","slug":"management","subChapters":[{"id":"80278306-0d51-5a46-abdb-638c41fd825d","slug":"benzodiazepine-z-drug-withdrawal","fullItemName":"Scenario: Benzodiazepine and z-drug withdrawal"}]},{"id":"b14f0631-9202-58fa-a823-a1f92f05ac08","fullItemName":"Prescribing information","slug":"prescribing-information","subChapters":[{"id":"22b2c65a-e4c1-5d8f-9260-f639540d94cb","slug":"diazepam","fullItemName":"Diazepam"}]},{"id":"3833e4c8-dbff-59bf-92ae-bd1c772444bb","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"d4659376-3ee7-5273-9fe9-08f5ce86d7d8","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"9bd84543-e92f-541d-80e5-17f0b36fcb90","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"d3ade608-7d7c-5174-9cad-8cecde797cd1","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"3e7141fe-bc43-5b07-81c4-1fb82ca82b2c","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"5c9aad6e-7321-5cc2-bad0-677e761afc6e","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"7a323840-12e0-545e-87de-461171f81997","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"351aac8e-ed32-587e-88b8-27ee3fa69f10","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"d4659376-3ee7-5273-9fe9-08f5ce86d7d8","slug":"how-this-topic-was-developed","fullItemName":"How this topic was developed"},"subChapters":[]}}},"staticQueryHashes":["3666801979"]}